It stated that Covaxin was the "only Covid vaccine" in government of India s COVID-19 immunisation program to have conducted efficacy trials in India. | Latest News India
AstraZeneca recently accepted that its Covid vaccines ‘Covishield’ and ‘Vaxzevria’ can, in very rare cases, cause Thrombosis Thrombocytopenia Syndrome (TTS). | Latest News India
AstraZeneca recently admitted that its Covid vaccines ‘Covishield’ and ‘Vaxzevria’ can, in very rare cases, cause Thrombosis Thrombocytopenia Syndrome (TTS). | Latest News India
The drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca.
The billionaire Indian family behind the world's largest vaccine producer Serum Institute of India (SII) is donating upwards of $60 million to Oxford University to fund its new research center, which will be home to the scientis